Theraclion Past Earnings Performance
Past criteria checks 0/6
Theraclion's earnings have been declining at an average annual rate of -1.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 11.9% per year.
Key information
-1.5%
Earnings growth rate
23.7%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | -11.9% |
| Return on equity | -108.5% |
| Net Margin | -277.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Theraclion makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -4 | 3 | 0 |
| 31 Mar 24 | 2 | -4 | 3 | 0 |
| 31 Dec 23 | 2 | -4 | 3 | 0 |
| 30 Sep 23 | 2 | -4 | 3 | 0 |
| 30 Jun 23 | 2 | -5 | 3 | 0 |
| 31 Mar 23 | 2 | -5 | 3 | 0 |
| 31 Dec 22 | 1 | -5 | 3 | 0 |
| 30 Sep 22 | 1 | -5 | 4 | 0 |
| 30 Jun 22 | 1 | -5 | 4 | 0 |
| 31 Mar 22 | 1 | -4 | 3 | 0 |
| 31 Dec 21 | 1 | -4 | 3 | 0 |
| 30 Sep 21 | 2 | -4 | 1 | 0 |
| 30 Jun 21 | 2 | -4 | 2 | 0 |
| 31 Mar 21 | 1 | -4 | 2 | 0 |
| 31 Dec 20 | 1 | -4 | 2 | 0 |
| 30 Sep 20 | 1 | -4 | 3 | 0 |
| 30 Jun 20 | 2 | -4 | 2 | 0 |
| 31 Mar 20 | 3 | -4 | 2 | 0 |
| 31 Dec 19 | 3 | -4 | 2 | 0 |
| 30 Sep 19 | 3 | -4 | 4 | 0 |
| 30 Jun 19 | 2 | -4 | 1 | 0 |
| 31 Mar 19 | 2 | -5 | 2 | 0 |
| 31 Dec 18 | 2 | -6 | 3 | 0 |
| 30 Sep 18 | 2 | -6 | 2 | 0 |
| 30 Jun 18 | 3 | -6 | 4 | 0 |
| 31 Mar 18 | 3 | -6 | 4 | 0 |
| 31 Dec 17 | 3 | -6 | 3 | 0 |
| 30 Sep 17 | 3 | -6 | 4 | 0 |
| 30 Jun 17 | 2 | -6 | 4 | 0 |
| 31 Mar 17 | 2 | -6 | 4 | 0 |
| 31 Dec 16 | 2 | -7 | 4 | 0 |
| 30 Sep 16 | 2 | -7 | 4 | 0 |
| 30 Jun 16 | 2 | -7 | 4 | 0 |
| 31 Mar 16 | 2 | -7 | 4 | 0 |
| 31 Dec 15 | 2 | -6 | 4 | 0 |
| 30 Sep 15 | 1 | -6 | 3 | 0 |
| 30 Jun 15 | 0 | -6 | 3 | 0 |
| 31 Mar 15 | 1 | -5 | 3 | 0 |
| 31 Dec 14 | 1 | -5 | 2 | 0 |
| 30 Sep 14 | 1 | -5 | 2 | 0 |
| 30 Jun 14 | 1 | -4 | 2 | 0 |
| 31 Mar 14 | 0 | -4 | 2 | 0 |
| 31 Dec 13 | 0 | -4 | 2 | 0 |
Quality Earnings: 941 is currently unprofitable.
Growing Profit Margin: 941 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 941 is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.
Accelerating Growth: Unable to compare 941's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 941 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: 941 has a negative Return on Equity (-108.48%), as it is currently unprofitable.